PRESS DIGEST -Wall Street Journal - January 13

Reuters01-13
PRESS DIGEST -Wall Street Journal - January 13

Jan 13 (Reuters) - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.

- AbbVie ABBV.N said on Monday that it has struck a three-year deal with U.S. President Donald Trump's administration to reduce drug prices, and has pledged $100 billion over the next decade for research and development in the country.

- OpenAI is expected to air a Super Bowl ad for the second straight year, escalating its battle for users as rival AI companies gain ground.

- The White House is weighing a last-ditch Iranian offer to engage in diplomacy over curbing its nuclear program even as President Trump currently leans toward authorizing fresh military strikes on Iran.

- Some Trump administration officials including Treasury Secretary Scott Bessent have expressed concern that the Justice Department's criminal investigation into Federal Reserve Chair Jerome Powell could imperil the president's nominees in the Senate and rattle financial markets.

- New York is preparing to loosen its environmental law to make it faster and cheaper to build housing in the state, the latest government effort to tackle high housing costs as affordability becomes a centerpiece of this election year.

- Paramount Skydance PSKY.O sued Warner Bros Discovery WBD.O on Monday for more information on a rival $82.7 billion deal with Netflix NFLX.O escalating a battle to take control of one of the most storied Hollywood studios.

(Compiled by Bengaluru newsroom)

((globalnewsmonitoring@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment